We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Submission

Enamel matrix derivative for the treatment of partially contained intrabony defects- a comparative study

Submitted

35 Views
0 Downloads
0 Saves

Presented at

EAO-2018

-

Presentation

thumbnail

Abstract

The aim of this study was to evaluate the use of enamel matrix derivative (EMD) alone or in association with deproteinized bovine bone mineral (DBBM) for the treatment of partially contained intrabony defects. A total of 29 intrabony defects were included. 9 self-contained defects (control group) and 10 partially contained defects (test group 1) were treated with EMD alone, while the other 10 partially contained defects (test group 2) were treated with a combination of EMD and DBBM. In all patients the papilla preservation technique was employed to raise the flap. At 12 months, probing depth (PD), recession (REC) and clinical attachment level (CAL) were respectively 2.3 ± 0.5 mm, 3.3 ± 2.0 mm and 5.6 ± 1.8 mm in the control group, 2.8 ± 0.8 mm, 2.3 ± 2.4 mm, and 5.0 ± 2.8 mm in test group 1, and 3.0 ± 0.7 mm, 3.9 ± 1.5 mm and 6.9 ± 1.1 mm in test group 2. Radiographic parameters confirmed a visible filling of all defects. No significant differences between groups were found. The results showed that partially contained defects could be successfully treated even using EMD alone when an appropriate technique for papilla preservation was applied.

Datasets

No datasets are available for this submission.

License

No license information is available for this submission.

Morressier

Company

Legal

Follow us

© Copyright 2020 Morressier GmbH. All rights reserved.

Morressier

© Copyright 2020 Morressier GmbH.
All rights reserved.